Abstract
A series of ruthenium complexes containing bis-benzimidazole derivatives have been synthesized and identified as able to target mitochondria and induce caspase-dependent apoptosis in cancer cells through superoxide overproduction.
Please wait while we load your content...
Supplementary files
Article information
- Article type
- Communication
- Submitted
- 16 Oct 2011
- Accepted
- 15 Nov 2011
- First published
- 09 Dec 2011
Dalton Trans., 2012,41, 1138-1141
Permissions
Ruthenium complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers
L. Li, Y. Wong, T. Chen, C. Fan and W. Zheng, Dalton Trans., 2012, 41, 1138 DOI: 10.1039/C1DT11950H
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
